All Articles

For every dollar lost to fraud, retailers now spend five more in hidden costs. This escalating crisis is forcing a choice between security and customer loyalty.

A tax evasion case reveals a web of immigration fraud, showcasing how Canada's agencies are forging new alliances to protect the system and its people.

As construction firm JFB Holdings pivots to AI combat, its partner XTEND lands major defense deals, revealing a potent growth model for the autonomous age.

Triller's audacious acquisition of a SpaceX stake sends its stock soaring, but can this high-stakes bet on a space giant save a company plagued by financial woes?

One year into its 2030 strategy, Domtar's new report reveals major gains in sustainability, from improved CDP scores to a historic land deal with an Indigenous Nation.

A new federal initiative taps in-home support leader Papa, signaling a major policy shift to integrate companionship and respite into formal dementia care.

A novel membrane technology promises to speed up production of next-gen medicines by solving a critical, energy-intensive bottleneck in pharmaceutical manufacturing.

As Toronto builds a massive waterfront community, a new library is its social centerpiece. But does this model of public-private partnership deliver on its promise?

An independent safety board just gave Medera's novel gene therapy for a stubborn form of heart failure a major endorsement, de-risking its path to the FDA.

Manufacturing giant Cummins is overhauling its global travel for 60,000+ staff with Navan's AI, a move signaling a major shift for legacy industries.

A new deal in Israel signals a shift from noisy, ineffective warnings to precise, life-saving insights. Is this the future of personalized medication safety?

The company once known for late-night snacks is pivoting hard, aiming to acquire a Taiwanese tech giant in a deal that could be worth over a billion dollars.

By combining vast datasets with patient-driven advocacy, a new alliance offers hope for angiosarcoma patients and a new model for rare disease research.

The chocolatier's dual openings signal growth, but a look at the books reveals a deeper story of strategic overhaul, franchisee faith, and a high-stakes pivot.

The firm's new API lets mainstream brokers offer crypto staking, turning a niche activity into a key tool for revenue and client retention.

The animal health leader faces scrutiny in its Q2 earnings call after a rocky first quarter. All eyes are on its strategy to balance market pressures with future-focused bets.

SUI Group's expanded loan to Bluefin isn't just a deal; it's a strategic maneuver to consolidate Sui's DeFi landscape and forge a new model for institutional investment.

Trintech's new AI agents automate tedious financial analysis, but the real story is its push for 'governed autonomy' in a high-stakes AI arms race.

Mint Inc. and YAS Digital Group are launching a joint venture to insure AI. Can their data-driven model unlock the next wave of automation in Asia?

NeuroSense's PrimeC shows intriguing biomarker activity against Alzheimer's, targeting multiple disease pathways. Is this the shift away from single-target drugs?